Home care service to ‘storm’ Abergele on Star Wars day in battle against Dementia – North Wales Pioneer
Biogen Provides Regulatory Update on the Supplemental Biologic License Application (sBLA) for Subcutaneous Administration of TYSABRI (natalizumab)